New funding announced yesterday for the UK Medicines and Healthcare products Regulatory Agency will be used to develop a “thorough but shortened process” to speed up the approval of innovative UK-developed products such as cancer vaccines and AI-based therapeutics for mental health conditions.
£10m Cash Boost For UK Regulator To Speed Up New Drug Approvals
Tax Relief Move ‘A Huge Boost’ For Biotech
An injection of new money should provide something of a shot in the arm for the UK’s drugs regulator as it deals with post-Brexit realities.
